Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: An immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up

British Journal of Cancer

Volumn 77, Issue 10, 1998, Pages 1661-1668

  Mauri, F A ^a   Caffo, O ^b   Veronese, S ^c   Verderio, P ^d   Boracchi, P ^d   Bonzanini, M ^b   Rossi, N ^e   Perrone, G ^a   Dalla Palma, P ^b   Barbareschi, M ^b  

^a SS Trinità Hospital   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breast neoplasm; Carcinoembryonic antigen; Immunohistochemistry; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 7144226570     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.273     Document Type: Article

References (18)

1. ASCO (1996) Clinical practice guidelines for the use of tumour markers in breast and colorectal cancer. J Clin Oncol 14: 2843-2877
2. Durrelman S and Simon R (1989) Flexible regression models with cubic splines. Stat Med 8: 551-561
3. Elston CW and Ellis IQ (1991) Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology 19: 403-410
4. Eskelinen M, Lipponen P and Syrjanen K (1992) Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathologic findings and survival. Anticancer Res 12: 91-95
5. Esteban JM, Paxton R, Mehta P, Battifora H and Shively JE (1993) Sensitivity and specificity of Gold types 1 to 5 anticarcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues. Hum Pathol 24: 322-328
6. Esteban JM, Felder B, Ahn C, Simpson JF, Battifora H and Shively JE (1994) Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients [see comments]. Cancer 74: 1575-1583
7. Gion M, Mione R, Dittadi R, Fasan S, Pallini A and Bruscagnin G (1986) Carcinoembryonic antigen, ferritin, TPA in serum and tissue: relationship with the receptor content in breast carcinoma. Cancer 57: 917-922
8. Harrell FE, Califf RM, Pryor DB, Kerny LL and Rosati RA (1982) Evaluating the yeld of medical tests. J Am Med Assoc 247: 2543-2548
9. Hayes DF, Bast RC, Desch CE, Fritsche H, Kemeny NE, Jessup JM, Locker GY, Macdonald JS, Mennel RG, Norton L, Ravdin P, Taube S and Winn RJ (1996) Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88: 1456-1466
10. Kuhujda FP, Offutt LE and Mendelshon G (1983) The distribution of carcinoembryonic antigen in breast carcinoma. Diagnostic and prognostic implications. Cancer 52: 1257-1264
11. Levesque MA, Diamandis EP, Yu H and Sutherland DJ (1994) Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer. Breast Cancer Res Treat 30: 174-195
12. Mansour EG, Hastert M, Park CH, Koehler KA and Petrelli M (1983) Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor. Cancer 51: 1243-1248
13. Molina R, Zanon G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Gimenez N, Pahisa J and Velasco M (1995) Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 36: 41-48
14. Neumeier M, Shively L, Chen FS, Gaida FJ, Ilgen C, Paxton RJ, Shively JE and Riggs AD (1990) Cloning for the genes for T84.66, an antibody that has a high specifieity and affinity for carcinoembryonic antigen, and expression of chimeric human-mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Cancer Res 50: 2128-2134
15. Sundblad AS, Pellicer EM and Ricci L (1996) Carcinoembrionic antigen expression in stages I and II breast cancer: its relationship with clinicopathologic factors. Hum Pathol 27: 297-301
16. Todd DW, Elston CW, Ellis IO, Hilton RW, Blamey RW and Haybittle JL (1987) Confirmation of a prognostic index in primary breast cancer, Br J Cancer 56: 489-492
17. Veronese S, Barbareschi M, Morelli L, Aldovini D, Mauri FA, Caffo O, Gambacorta M and Dalla Palma P (1995) Predictive value of HR1D5 antibody immunostaining in breast cancer. Appl Immunohistochem 3: 85-90
18. Walker RA (1980) Demonstration of carcinoembryonic antigen in human breast carcinomas by the immnnoperoxidase technique. J Clin Pathol 33: 356-360